Company
Friulchem S.p.A.
Headquarters: Milan, MI, Italy
Employees: 36
CEO: Mr. Disma Giovanni Mazzola
Market Cap
€6.3 Million
EUR as of Jan. 1, 2024
US$7.0 Million
Friulchem S.p.A. Categories
Italy Healthcare Drug Manufacturers—Specialty & GenericItaly Healthcare Italy Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Friulchem S.p.A. engages in the research, development, and production of original and generic pharmaceutical products for human and veterinary fields in Italy. It offers generic cosmoceuticals and food supplements; chewable cubes for animals; and cosmetic products for pigmentation disorders. The company is based in Milan, Italy.
Top 1-year algo backtest: +191.38%
$10,000 in June 2023 would now be $29,138 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Friulchem S.p.A. has the following listings and related stock indices.
Stock: MTA: FCM wb_incandescent